Next Article in Journal
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
Next Article in Special Issue
Off-Label Use of COVID-19 Vaccines from Ethical Issues to Medico-Legal Aspects: An Italian Perspective
Previous Article in Journal
Recombinant Toxoplasma gondii Ribosomal Protein P2 Modulates the Functions of Murine Macrophages In Vitro and Provides Immunity against Acute Toxoplasmosis In Vivo
 
 
Article

Article Versions Notes

Vaccines 2021, 9(4), 358; https://doi.org/10.3390/vaccines9040358
Action Date Notes Link
article xml file uploaded 8 April 2021 13:24 CEST Original file -
article xml uploaded. 8 April 2021 13:24 CEST Update -
article pdf uploaded. 8 April 2021 13:24 CEST Version of Record -
article html file updated 8 April 2021 13:25 CEST Original file -
article xml file uploaded 8 April 2021 13:50 CEST Update -
article xml uploaded. 8 April 2021 13:50 CEST Update https://www.mdpi.com/2076-393X/9/4/358/xml
article pdf uploaded. 8 April 2021 13:50 CEST Updated version of record https://www.mdpi.com/2076-393X/9/4/358/pdf
article html file updated 8 April 2021 13:51 CEST Update -
article html file updated 11 April 2021 15:20 CEST Update -
article html file updated 4 August 2021 16:47 CEST Update -
article html file updated 25 July 2022 11:17 CEST Update https://www.mdpi.com/2076-393X/9/4/358/html
Back to TopTop